1.
Parimi S, Tsang E, Alexander A, McKenzie M, Bachand F, Sunderland K, et al. A population-based study of the use of radium 223 in metastatic castration-resistant prostate cancer: Factors associated with treatment completion. CUAJ [Internet]. 2017 Oct. 12 [cited 2026 Apr. 30];11(10):350-5. Available from: https://cuaj.ca/index.php/journal/article/view/4415